Roger Collet-Vidiella, Pol Camps-Renom, Ana Núñez-Guillén, Helena Quesada, Federica Rizzo, Noelia Rodriguez-Villatoro, Sergio Amaro, Laura Llull, Daniel Santana, Edgardo Estrada, Alan Flores, Mikel Terceño, Saima Bashir, María Hernández-Pérez, Sebastià Remollo, Oriol Barrachina-Esteve, David Cánovas, Elio Vivas, Ana Rodríguez-Campello, Gerard Mauri, Francisco Purroy, Anna Ramos-Pachón, Marina Guasch-Jiménez, Daniel Guisado-Alonso, Luis Prats-Sánchez, Alejandro Martínez-Domeño, Álvaro Lambea-Gil, Garbiñe Ezcurra-Díaz, Jordi Branera-Pujol, José Pablo Martínez-González, Lavinia Dinia, Mercè Salvat-Plana, Natalia Pérez de la Ossa, Carlos A Molina, Pere Cardona, Joan Martí-Fàbregas
{"title":"Rescue stenting after failed mechanical thrombectomy: The RES-CAT study.","authors":"Roger Collet-Vidiella, Pol Camps-Renom, Ana Núñez-Guillén, Helena Quesada, Federica Rizzo, Noelia Rodriguez-Villatoro, Sergio Amaro, Laura Llull, Daniel Santana, Edgardo Estrada, Alan Flores, Mikel Terceño, Saima Bashir, María Hernández-Pérez, Sebastià Remollo, Oriol Barrachina-Esteve, David Cánovas, Elio Vivas, Ana Rodríguez-Campello, Gerard Mauri, Francisco Purroy, Anna Ramos-Pachón, Marina Guasch-Jiménez, Daniel Guisado-Alonso, Luis Prats-Sánchez, Alejandro Martínez-Domeño, Álvaro Lambea-Gil, Garbiñe Ezcurra-Díaz, Jordi Branera-Pujol, José Pablo Martínez-González, Lavinia Dinia, Mercè Salvat-Plana, Natalia Pérez de la Ossa, Carlos A Molina, Pere Cardona, Joan Martí-Fàbregas","doi":"10.1177/23969873241308680","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The efficacy of intracranial rescue stenting (RS) following failed mechanical thrombectomy (MT) in large-vessel occlusion (LVO) stroke remains uncertain. We aimed to evaluate clinical outcomes of RS in patients with anterior circulation LVO stroke following unsuccessful MT.</p><p><strong>Patients and methods: </strong>We conducted a retrospective analysis using the Stroke Code Registry of Catalonia (January 2016-March 2022), a prospective, population-based registry including patients treated at 10 comprehensive stroke centers. We compared outcomes between patients who received RS and those who did not after failed MT. The primary outcome was the shift in 90-day functional status, assessed by the modified Rankin Scale (mRS), adjusted for confounders using inverse probability of treatment weighting (IPTW). Secondary outcomes included good (mRS ⩽ 2 or 3 if baseline mRS was 3) and excellent (mRS ⩽ 1) outcomes, ischemic recurrences, hemorrhagic transformation, and 90-day mortality.</p><p><strong>Results: </strong>Of 601 patients, 69 underwent RS. RS did not significantly impact the 90-day mRS shift (adjusted common odds ratio [acOR] 1.06, [95% CI 0.85-1.32]; <i>p</i> = 0.613). However, RS was associated with higher rates of good (18.8% vs 11.7%; aOR 1.41, [95% CI 1.00-1.99]; <i>p</i> = 0.048) and excellent outcomes (17.4% vs 5.7%; aOR 2.90, [95% CI 1.89-4.43]; <i>p</i> < 0.001). Symptomatic intracranial hemorrhage (9.4% vs 7.4%; <i>p</i> = 0.507) and 90-day mortality (30.4% vs 39.8%; <i>p</i> = 0.135) were similar between groups. Stroke recurrence (4.2% vs 1.7%; <i>p</i> = 0.247) showed no significant difference at 33-month follow-up.</p><p><strong>Discussion and conclusion: </strong>RS may increase the likelihood of good and excellent outcomes in anterior LVO stroke after failed MT, without increasing long-term risks. Further randomized trials are warranted for comprehensive validation.</p>","PeriodicalId":46821,"journal":{"name":"European Stroke Journal","volume":" ","pages":"23969873241308680"},"PeriodicalIF":5.8000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694265/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Stroke Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/23969873241308680","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The efficacy of intracranial rescue stenting (RS) following failed mechanical thrombectomy (MT) in large-vessel occlusion (LVO) stroke remains uncertain. We aimed to evaluate clinical outcomes of RS in patients with anterior circulation LVO stroke following unsuccessful MT.
Patients and methods: We conducted a retrospective analysis using the Stroke Code Registry of Catalonia (January 2016-March 2022), a prospective, population-based registry including patients treated at 10 comprehensive stroke centers. We compared outcomes between patients who received RS and those who did not after failed MT. The primary outcome was the shift in 90-day functional status, assessed by the modified Rankin Scale (mRS), adjusted for confounders using inverse probability of treatment weighting (IPTW). Secondary outcomes included good (mRS ⩽ 2 or 3 if baseline mRS was 3) and excellent (mRS ⩽ 1) outcomes, ischemic recurrences, hemorrhagic transformation, and 90-day mortality.
Results: Of 601 patients, 69 underwent RS. RS did not significantly impact the 90-day mRS shift (adjusted common odds ratio [acOR] 1.06, [95% CI 0.85-1.32]; p = 0.613). However, RS was associated with higher rates of good (18.8% vs 11.7%; aOR 1.41, [95% CI 1.00-1.99]; p = 0.048) and excellent outcomes (17.4% vs 5.7%; aOR 2.90, [95% CI 1.89-4.43]; p < 0.001). Symptomatic intracranial hemorrhage (9.4% vs 7.4%; p = 0.507) and 90-day mortality (30.4% vs 39.8%; p = 0.135) were similar between groups. Stroke recurrence (4.2% vs 1.7%; p = 0.247) showed no significant difference at 33-month follow-up.
Discussion and conclusion: RS may increase the likelihood of good and excellent outcomes in anterior LVO stroke after failed MT, without increasing long-term risks. Further randomized trials are warranted for comprehensive validation.
导言:大血管闭塞(LVO)脑卒中机械取栓(MT)失败后颅内支架置入术(RS)的疗效尚不确定。我们的目的是评估前循环LVO卒中患者在治疗失败后RS的临床结果。患者和方法:我们使用加泰罗尼亚卒中代码登记处(2016年1月- 2022年3月)进行了回顾性分析,这是一个前瞻性的、基于人群的登记处,包括在10个综合卒中中心接受治疗的患者。我们比较了MT失败后接受RS和未接受RS的患者之间的结果。主要结果是90天功能状态的变化,通过修改的Rankin量表(mRS)评估,使用治疗加权逆概率(IPTW)对混杂因素进行调整。次要结局包括良好(如果基线mRS为3,则mRS≥2或≥3)和优良(mRS≥1)结局、缺血复发、出血转化和90天死亡率。结果:在601例患者中,69例患者接受了RS, RS对90天mRS变化无显著影响(调整后的常见优势比[acOR] 1.06, [95% CI 0.85-1.32];p = 0.613)。然而,RS与较高的良好率相关(18.8% vs 11.7%;aOR 1.41, [95% CI 1.00-1.99];P = 0.048)和预后良好(17.4% vs 5.7%;aOR 2.90, [95% CI 1.89-4.43];P = 0.507)和90天死亡率(30.4% vs 39.8%;P = 0.135),组间相似。卒中复发率(4.2% vs 1.7%;P = 0.247)在33个月的随访中差异无统计学意义。讨论和结论:RS可能增加MT失败后前左左脑卒中良好和优异结局的可能性,但不增加长期风险。需要进一步的随机试验进行全面验证。
期刊介绍:
Launched in 2016 the European Stroke Journal (ESJ) is the official journal of the European Stroke Organisation (ESO), a professional non-profit organization with over 1,400 individual members, and affiliations to numerous related national and international societies. ESJ covers clinical stroke research from all fields, including clinical trials, epidemiology, primary and secondary prevention, diagnosis, acute and post-acute management, guidelines, translation of experimental findings into clinical practice, rehabilitation, organisation of stroke care, and societal impact. It is open to authors from all relevant medical and health professions. Article types include review articles, original research, protocols, guidelines, editorials and letters to the Editor. Through ESJ, authors and researchers have gained a new platform for the rapid and professional publication of peer reviewed scientific material of the highest standards; publication in ESJ is highly competitive. The journal and its editorial team has developed excellent cooperation with sister organisations such as the World Stroke Organisation and the International Journal of Stroke, and the American Heart Organization/American Stroke Association and the journal Stroke. ESJ is fully peer-reviewed and is a member of the Committee on Publication Ethics (COPE). Issues are published 4 times a year (March, June, September and December) and articles are published OnlineFirst prior to issue publication.